TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
TransMedics (NASDAQ: TMDX), a medical technology company focused on organ transplant therapy, has scheduled its Second Quarter 2025 financial results announcement for July 30, 2025, after market close.
The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. Investors can join via phone using specific dial-in numbers or access the webcast through TransMedics' investor relations website.
TransMedics (NASDAQ: TMDX), un'azienda di tecnologia medica specializzata nella terapia del trapianto di organi, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025, dopo la chiusura del mercato.
L'azienda terr脿 una conference call alle 16:30 ET / 13:30 PT per discutere i risultati. Gli investitori potranno partecipare telefonicamente utilizzando numeri di accesso specifici o seguire la trasmissione web tramite il sito web delle relazioni con gli investitori di TransMedics.
TransMedics (NASDAQ: TMDX), una empresa de tecnolog铆a m茅dica enfocada en la terapia de trasplante de 贸rganos, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025, despu茅s del cierre del mercado.
La compa帽铆a realizar谩 una llamada conferencia a las 4:30 p.m. ET / 1:30 p.m. PT para discutir los resultados. Los inversores pueden unirse por tel茅fono usando n煤meros espec铆ficos o acceder a la transmisi贸n web a trav茅s del sitio web de relaciones con inversores de TransMedics.
TransMedics (NASDAQ: TMDX)電� 鞛リ赴 鞚挫嫕 旃橂鞐� 欷戩爯鞚� 霊� 鞚橂 旮办垹 須岇偓搿�, 2025雲� 7鞗� 30鞚� 2攵勱赴 2025雲� 鞛 鞁れ爜 氚滍憸毳� 鞁滌灔 毵堦皭 頉勳棎 鞓堨爼頄堨姷雼堧嫟.
须岇偓电� 霃欕秬 響滌鞁� 鞓ろ泟 4鞁� 30攵� / 韮滍弶鞏� 響滌鞁� 鞓ろ泟 1鞁� 30攵�鞐� 旎嵓霟办姢 旖滌潉 臧滌禍頃橃棳 鞁れ爜鞚� 雲检潣頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� 韸轨爼 鞝勴檾 氩堩樃毳� 韱淀暣 彀胳棳頃橁卑雮� TransMedics 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟.
TransMedics (NASDAQ : TMDX), une soci茅t茅 de technologie m茅dicale sp茅cialis茅e dans la th茅rapie de transplantation d'organes, a pr茅vu l'annonce des r茅sultats financiers du deuxi猫me trimestre 2025 pour le 30 juillet 2025, apr猫s la cl么ture du march茅.
La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 16h30 ET / 13h30 PT pour discuter des r茅sultats. Les investisseurs peuvent participer par t茅l茅phone en utilisant des num茅ros d'appel sp茅cifiques ou acc茅der au webinaire via le site des relations investisseurs de TransMedics.
TransMedics (NASDAQ: TMDX), ein Medizintechnikunternehmen mit Schwerpunkt auf Organtransplantationstherapie, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r den 30. Juli 2025 nach B枚rsenschluss angesetzt.
Das Unternehmen wird um 16:30 Uhr ET / 13:30 Uhr PT eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren k枚nnen per Telefon 眉ber spezifische Einwahlnummern teilnehmen oder den Webcast 眉ber die Investor-Relations-Website von TransMedics verfolgen.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing (844) 676-6010 for domestic callers or (412) 634-6944 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at .
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
[email protected]听
View original content to download multimedia:
SOURCE TransMedics Group, Inc.
FAQ
When will TransMedics (TMDX) release Q2 2025 earnings?
What time is the TransMedics Q2 2025 earnings call?
How can investors join the TransMedics Q2 2025 earnings call?
Where can I access the webcast of TransMedics Q2 2025 earnings call?
